Park Medi World Limited announced on June 05, 2026, that its wholly owned subsidiary, Aggarwal Hospital and Research Services Private Limited, has divested its entire 55% shareholding in Devina Derma Private Limited for a consideration of INR 0.06 crore. The strategic move, part of the group's restructuring initiatives, was undertaken due to the sellers' failure to fulfil certain pre-requisite conditions stipulated under transactional documents, which posed a risk to operational efficiency and financial flexibility. Upon completion of the sale, Devina Derma Private Limited has ceased to be a subsidiary of Aggarwal Hospital and Research Services Private Limited and, consequently, of Park Medi World Limited.

The divestment was approved by the Board of Directors of Aggarwal Hospital and Research Services Private Limited. Management views the decision as prudent and value-accretive, allowing the group to streamline its corporate structure and focus resources on core strategic priorities. The buyer, Zen Zone Healthcare Private Limited, is not part of the promoter or promoter group of Park Medi World Limited.

The transaction details were disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated January 30, 2026. The agreement for sale was entered into on June 05, 2026, with the sale concluding on the same day.

Financial disclosures regarding the divested entity indicate that Devina Derma Private Limited recorded a turnover of Rs. 0.45 crores for the financial year ended March 31, 2026. This constituted approximately 0.03% of the consolidated turnover of Park Medi World Limited. Additionally, the subsidiary had a negative net worth of INR (0.34).

The following table outlines the key details of the transaction as per the regulatory filing:

Park Medi World Limited stated that it remains committed to enhancing long-term stakeholder value and strengthening its competitive positioning through such strategic initiatives. The group continues to evaluate measures to sustain growth momentum across its operational footprint.

Park Medi World has announced the execution of a definitive agreement to acquire 100% of the shareholding of The Medicity Hospital in Rudrapur, Uttarakhand. The all-cash transaction is valued at approximately ₹177 Crores, marking the company's entry into the state of Uttarakhand and expanding its presence to a sixth state.

Acquisition Details

The target entity, V3 Healthcare Private Limited, owns and operates The Medicity Hospital. The transaction involves acquiring 80% of the shareholding by August 31, 2026, and the remaining 20% after March 31, 2030. The acquisition does not fall under related party transactions.

Strategic Significance

The Medicity Hospital is a multi-super speciality healthcare institution and the largest hospital in the Kumaon region. Spanning approximately 1.64 lakh square feet, the facility is NABH-accredited and offers over 20 specialities, including Cardiac Sciences, Neurosurgery, and Oncology. The hospital reported a turnover of INR 55.74 crores for the financial year 2025-26 (unaudited).

This acquisition aligns with Park Medi World's strategy to maximize operational synergies and achieve economies of scale in high-potential markets. The company stated that the addition of this facility is expected to be earnings-accretive and will strengthen its consolidated financial performance through enhanced clinical offerings and improved bed utilisation rates.

Financial Performance

The target entity has demonstrated consistent growth over the past three years.

Park Medi World currently operates 16 hospitals with a combined capacity of 3,960 beds. With the integration of The Medicity Hospital and other ongoing projects, the group expects its total capacity to reach 5,790 beds by March 2028.